|
|
cell adhesion
|
GO:0007155 |
329 |
0.170
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.157
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.135
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.106
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.100
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.096
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.093
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.093
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.092
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.091
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.080
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.079
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.076
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.075
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.073
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.072
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.072
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.070
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.069
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.068
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.068
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.068
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.068
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.066
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.065
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.064
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.063
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.063
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.061
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.061
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.061
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.060
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.060
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.060
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.060
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.059
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.058
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.057
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.057
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.056
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.056
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.055
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.055
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.055
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.054
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.054
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.054
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.054
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.053
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.053
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.052
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.051
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.051
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.051
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.051
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.051
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.050
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.049
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.049
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.049
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.048
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.048
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.047
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.047
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.047
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.047
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.046
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.046
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.046
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.045
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.045
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.045
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.043
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.043
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.043
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.042
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.042
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.041
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.041
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.041
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.041
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.041
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.041
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.040
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.040
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.040
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.040
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.039
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.039
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.039
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.039
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.038
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.037
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.036
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.036
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.035
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.035
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.035
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.035
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.035
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.034
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.034
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.034
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.034
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.034
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.034
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.034
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.034
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.032
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.032
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.032
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.032
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.032
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.032
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.031
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.031
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.030
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.030
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.030
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.029
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.029
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.028
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.028
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.028
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.028
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.027
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.027
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.026
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.025
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.025
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.025
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.025
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.025
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.025
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.025
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.025
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.025
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.025
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.024
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.024
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.024
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.024
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.024
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.024
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.024
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.023
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.022
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.022
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.022
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.022
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.022
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.021
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.021
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.021
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.021
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.021
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.021
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.021
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.020
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.020
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.020
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.020
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.020
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.020
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.020
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.020
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.019
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.019
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.019
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.019
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.019
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.019
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.019
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.019
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.019
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.019
|
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.019
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.018
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.018
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.018
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.018
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.017
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.017
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.017
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.017
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.017
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.017
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.017
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.016
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.016
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.016
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.016
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.016
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.016
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.016
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.016
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.016
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.016
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.016
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.016
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.016
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.016
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.015
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.015
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.015
|
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.015
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.015
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.015
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.015
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.015
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.015
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.015
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.015
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.015
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.015
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.015
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.015
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.015
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.015
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.015
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.015
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.014
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.014
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.014
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.014
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.014
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.014
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.014
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.014
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.014
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.014
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.014
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.014
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.014
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.014
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.014
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.014
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.014
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.013
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.013
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.013
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.013
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.013
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.013
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.013
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.013
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.013
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.013
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.013
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.012
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.012
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.012
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.012
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.012
|
|
|
|
neuroblast division in subventricular zone
|
GO:0021849 |
2 |
0.012
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.012
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.012
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.012
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.012
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.012
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.012
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.012
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.012
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.012
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.012
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.012
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.012
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.012
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.011
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.011
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.011
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.011
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.011
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.011
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.011
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.011
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.011
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.011
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.011
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.011
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.011
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.011
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.011
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.011
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.011
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.011
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.011
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.011
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.011
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.011
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.011
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.011
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.011
|
|
|
|
translation
|
GO:0006412 |
93 |
0.011
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.011
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.011
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.011
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.011
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.011
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.011
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.011
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.011
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.010
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.010
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.010
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.010
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.010
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.010
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.010
|
|
